Literature DB >> 28659469

ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair.

Chun-Chin Chen1,2, Elizabeth M Kass1, Wei-Feng Yen2,3, Thomas Ludwig4, Mary Ellen Moynahan5, Jayanta Chaudhuri3, Maria Jasin6,2.   

Abstract

BRCA1 is essential for homology-directed repair (HDR) of DNA double-strand breaks in part through antagonism of the nonhomologous end-joining factor 53BP1. The ATM kinase is involved in various aspects of DNA damage signaling and repair, but how ATM participates in HDR and genetically interacts with BRCA1 in this process is unclear. To investigate this question, we used the Brca1S1598F mouse model carrying a mutation in the BRCA1 C-terminal domain of BRCA1. Whereas ATM loss leads to a mild HDR defect in adult somatic cells, we find that ATM inhibition leads to severely reduced HDR in Brca1S1598F cells. Consistent with a critical role for ATM in HDR in this background, loss of ATM leads to synthetic lethality of Brca1S1598F mice. Whereas both ATM and BRCA1 promote end resection, which can be regulated by 53BP1, 53bp1 deletion does not rescue the HDR defects of Atm mutant cells, in contrast to Brca1 mutant cells. These results demonstrate that ATM has a role in HDR independent of the BRCA1-53BP1 antagonism and that its HDR function can become critical in certain contexts.

Entities:  

Keywords:  ATM; BRCA1; homologous recombination; homology-directed repair; olaparib

Mesh:

Substances:

Year:  2017        PMID: 28659469      PMCID: PMC5530697          DOI: 10.1073/pnas.1706392114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

2.  Correct end use during end joining of multiple chromosomal double strand breaks is influenced by repair protein RAD50, DNA-dependent protein kinase DNA-PKcs, and transcription context.

Authors:  Amanda Gunn; Nicole Bennardo; Anita Cheng; Jeremy M Stark
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

3.  A role for the MRN complex in ATR activation via TOPBP1 recruitment.

Authors:  Anja M Duursma; Robert Driscoll; Josh E Elias; Karlene A Cimprich
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

4.  CtIP links DNA double-strand break sensing to resection.

Authors:  Zhongsheng You; Linda Z Shi; Quan Zhu; Peng Wu; You-Wei Zhang; Andrew Basilio; Nina Tonnu; Inder M Verma; Michael W Berns; Tony Hunter
Journal:  Mol Cell       Date:  2009-12-25       Impact factor: 17.970

5.  A mechanism for the suppression of homologous recombination in G1 cells.

Authors:  Alexandre Orthwein; Sylvie M Noordermeer; Marcus D Wilson; Sébastien Landry; Radoslav I Enchev; Alana Sherker; Meagan Munro; Jordan Pinder; Jayme Salsman; Graham Dellaire; Bing Xia; Matthias Peter; Daniel Durocher
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

6.  Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase.

Authors:  Elizabeth M Kass; Hildur R Helgadottir; Chun-Chin Chen; Maria Barbera; Raymond Wang; Ulrica K Westermark; Thomas Ludwig; Mary Ellen Moynahan; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

7.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition.

Authors:  J Ross Chapman; Inger Brandsma; Guotai Xu; Jingsong Yuan; Martin Mistrik; Peter Bouwman; Jirina Bartkova; Ewa Gogola; Daniël Warmerdam; Marco Barazas; Janneke E Jaspers; Kenji Watanabe; Mark Pieterse; Ariena Kersbergen; Wendy Sol; Patrick H N Celie; Philip C Schouten; Bram van den Broek; Ahmed Salman; Marja Nieuwland; Iris de Rink; Jorma de Ronde; Kees Jalink; Simon J Boulton; Junjie Chen; Dik C van Gent; Jiri Bartek; Jos Jonkers; Piet Borst; Sven Rottenberg
Journal:  Nature       Date:  2015-03-23       Impact factor: 49.962

8.  ATM limits incorrect end utilization during non-homologous end joining of multiple chromosome breaks.

Authors:  Nicole Bennardo; Jeremy M Stark
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

9.  The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression.

Authors:  Colleen R Reczek; Matthias Szabolcs; Jeremy M Stark; Thomas Ludwig; Richard Baer
Journal:  J Cell Biol       Date:  2013-05-27       Impact factor: 10.539

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312

View more
  28 in total

Review 1.  Control of meiotic double-strand-break formation by ATM: local and global views.

Authors:  Agnieszka Lukaszewicz; Julian Lange; Scott Keeney; Maria Jasin
Journal:  Cell Cycle       Date:  2018-07-15       Impact factor: 4.534

Review 2.  Synthetic Lethality through the Lens of Medicinal Chemistry.

Authors:  Samuel H Myers; Jose Antonio Ortega; Andrea Cavalli
Journal:  J Med Chem       Date:  2020-11-02       Impact factor: 7.446

3.  BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

Authors:  Dali Zong; Salomé Adam; Yifan Wang; Hiroyuki Sasanuma; Elsa Callén; Matilde Murga; Amanda Day; Michael J Kruhlak; Nancy Wong; Meagan Munro; Arnab Ray Chaudhuri; Baktiar Karim; Bing Xia; Shunichi Takeda; Neil Johnson; Daniel Durocher; André Nussenzweig
Journal:  Mol Cell       Date:  2019-01-28       Impact factor: 17.970

4.  Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.

Authors:  Chen Wang; Huanyin Tang; Anke Geng; Binghua Dai; Haiping Zhang; Xiaoxiang Sun; Yu Chen; Zhibing Qiao; Hong Zhu; Jiamei Yang; Jiayu Chen; Qizhi He; Nan Qin; Jinru Xie; Rong Tan; Xiaoping Wan; Shaorong Gao; Ying Jiang; Fang-Lin Sun; Zhiyong Mao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

5.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

6.  A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

Authors:  Marta Castroviejo-Bermejo; Cristina Cruz; Alba Llop-Guevara; Sara Gutiérrez-Enríquez; Mandy Ducy; Yasir Hussein Ibrahim; Albert Gris-Oliver; Benedetta Pellegrino; Alejandra Bruna; Marta Guzmán; Olga Rodríguez; Judit Grueso; Sandra Bonache; Alejandro Moles-Fernández; Guillermo Villacampa; Cristina Viaplana; Patricia Gómez; Maria Vidal; Vicente Peg; Xavier Serres-Créixams; Graham Dellaire; Jacques Simard; Paolo Nuciforo; Isabel T Rubio; Rodrigo Dienstmann; J Carl Barrett; Carlos Caldas; José Baselga; Cristina Saura; Javier Cortés; Olivier Déas; Jos Jonkers; Jean-Yves Masson; Stefano Cairo; Jean-Gabriel Judde; Mark J O'Connor; Orland Díez; Judith Balmaña; Violeta Serra
Journal:  EMBO Mol Med       Date:  2018-12       Impact factor: 12.137

7.  NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.

Authors:  Yanan Yu; Kwangmin Choi; Jianqiang Wu; Paul R Andreassen; Phillip J Dexheimer; Mehdi Keddache; Hilde Brems; Robert J Spinner; Jose A Cancelas; Lisa J Martin; Margaret R Wallace; Eric Legius; Kristine S Vogel; Nancy Ratner
Journal:  Acta Neuropathol       Date:  2019-10-29       Impact factor: 17.088

Review 8.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

9.  BRCA1 Mutational Complementation Induces Synthetic Viability.

Authors:  Joseph Nacson; Daniela Di Marcantonio; Yifan Wang; Andrea J Bernhardy; Emma Clausen; Xiang Hua; Kathy Q Cai; Esteban Martinez; Wanjuan Feng; Elsa Callén; Wei Wu; Gaorav P Gupta; Joseph R Testa; André Nussenzweig; Stephen M Sykes; Neil Johnson
Journal:  Mol Cell       Date:  2020-04-30       Impact factor: 17.970

Review 10.  Natural products targeting cancer cell dependency.

Authors:  Changxiang Shi; Eun Ju Yang; Shishi Tao; Guowen Ren; Pui Kei Mou; Joong Sup Shim
Journal:  J Antibiot (Tokyo)       Date:  2021-06-23       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.